{"id":"levofloxacin-dexamethasone-followed-by-dexamethasone","safety":{"commonSideEffects":[{"rate":null,"effect":"Tendinopathy"},{"rate":null,"effect":"QT prolongation"},{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Immunosuppression"},{"rate":null,"effect":"Gastrointestinal disturbance"}]},"_chembl":{"chemblId":"CHEMBL1697787","moleculeType":"Small molecule","molecularWeight":"528.57"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Levofloxacin works by inhibiting bacterial DNA replication and transcription through topoisomerase inhibition, effectively killing susceptible bacteria. Dexamethasone, administered sequentially, reduces inflammation and immune-mediated tissue damage that may accompany or follow infection. This combination approach targets both the infectious agent and the inflammatory response.","oneSentence":"Levofloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, while dexamethasone is a corticosteroid that suppresses inflammation and immune responses.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:18:45.038Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial infection with associated inflammation (specific indication not publicly detailed for this Phase 3 trial)"}]},"trialDetails":[{"nctId":"NCT04371445","phase":"PHASE4","title":"Dextenza in the Post-op Management of Vitreoretinal Surgeries","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2020-06-01","conditions":"Vitreoretinal Surgery, Ocular Inflammation, Post-operative Pain","enrollment":30},{"nctId":"NCT05739682","phase":"NA","title":"Pain and Microbial Reduction of Antimicrobial Corticosteroid Mixture Versus Cryotherapy in Necrotic Teeth","status":"COMPLETED","sponsor":"Cairo University","startDate":"2024-07-01","conditions":"Dental Pulp Necrosis","enrollment":28},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT04200651","phase":"PHASE4","title":"Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery","status":"TERMINATED","sponsor":"The New York Eye Surgery Center","startDate":"2020-01-13","conditions":"Glaucoma, Cataract","enrollment":25},{"nctId":"NCT03739528","phase":"PHASE3","title":"Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery","status":"COMPLETED","sponsor":"NTC srl","startDate":"2018-09-03","conditions":"Cataract","enrollment":808},{"nctId":"NCT02551796","phase":"NA","title":"Early Changes Among FLEx, LASIK and FS-LASIK","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2015-09","conditions":"Myopia, Astigmatism","enrollment":75}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":27,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Levofloxacin + dexamethasone followed by Maxidex"],"phase":"phase_3","status":"active","brandName":"Levofloxacin + dexamethasone followed by dexamethasone","genericName":"Levofloxacin + dexamethasone followed by dexamethasone","companyName":"NTC srl","companyId":"ntc-srl","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Levofloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, while dexamethasone is a corticosteroid that suppresses inflammation and immune responses. Used for Bacterial infection with associated inflammation (specific indication not publicly detailed for this Phase 3 trial).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}